Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2.

Kitanovski, Simo; Horemheb-Rubio, Gibran; Adams, Ortwin; Gärtner, Barbara; Lengauer, Thomas; Hoffmann, Daniel; Kaiser, Rolf

Kitanovski, Simo; Horemheb-Rubio, Gibran; Adams, Ortwin; Gärtner, Barbara; Lengauer, Thomas; Hoffmann, Daniel; Kaiser, Rolf.

Afiliación

Kitanovski S; Bioinformatics and Computational Biophysics, Faculty of Biology and Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, 45141, Germany.
Horemheb-Rubio G; Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, 50935, Germany.
Adams O; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, 14080, Mexico.
Gärtner B; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, 40225, Germany.
Lengauer T; Institute of Medical Microbiology and Hygiene, Saarland University Medical Center, Homburg, 66421, Germany.
Hoffmann D; Computational Biology, Max Planck Institute for Informatics, Saarland Informatics Campus, Saarbrücken, 66123, Germany.
Kaiser R; Bioinformatics and Computational Biophysics, Faculty of Biology and Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, 45141, Germany. daniel.hoffmann@uni-due.de.

BMC Public Health ; 21(1): 1178, 2021 06 21.

Article en En | MEDLINE | ID: mdl-34154549

Asunto(s)

COVID-19; Rhinovirus; Teorema de Bayes; Alemania; Humanos; Prevalencia; SARS-CoV-2

Palabras clave

Bayesian; COVID-19; Germany; Modeling; Rhinovirus; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rhinovirus / COVID-19 Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google